2024-11-20 15:35:06
Eccogene Announces Completed First-in-human of ECC0509 in Phase 1a Clinical Trial in Australia
Health/ 2023-07-22
Eccogene Announces Completed First-in-hu...

SHANGHAI,July 28,2021-- Eccogene,Inc.,a clinical stage biopharmaceutical company focused on discovery and development of metabolic and immun...

I-Mab Announces IND Acceptance for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China
Corporate/ 2023-07-23
I-Mab Announces IND Acceptance for Phase...

Efineptakin alfa in combination with pembrolizumab induced 27.8% ORR in metastatic TNBC patients in a phase 1b/2 trial in South Korea

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release